The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prediction of survival outcomes in NSCLC using a new PRO index from the LCSS (Lung Cancer Symptom Scale): Results of a 622-patient prospective trial.
Richard J. Gralla
Research Funding - Sanofi
Patricia J Hollen
Research Funding - Sanofi
Sumitra Thongprasert
No relevant relationships to disclose
Hoon-Kyo Kim
No relevant relationships to disclose
Te-Chun Hsia
No relevant relationships to disclose
Shi Yuankai
No relevant relationships to disclose
Nina Kohn
No relevant relationships to disclose
Martin Lesser
No relevant relationships to disclose